0
0

Cart (0)

Home > Categories > Somatostatin

Somatostatin

Sort by
Wishlist

D-Cys(14)-Somatostatin

  • CAT NUMBER DCTI-D-166
  • CAS NUMBER NA
  • MOLECULAR FORMULA C76H104N18O19S2
  • MOLECULAR WEIGHT 1637.89
Wishlist
Wishlist

D-Cys(3)-Somatostatin

  • CAT NUMBER DCTI-D-161
  • CAS NUMBER NA
  • MOLECULAR FORMULA C76H104N18O19S2
  • MOLECULAR WEIGHT 1637.89
Wishlist
Wishlist

D-Lys(4)-Somatostatin

  • CAT NUMBER DCTI-D-162
  • CAS NUMBER NA
  • MOLECULAR FORMULA C76H104N18O19S2
  • MOLECULAR WEIGHT 1637.89
Wishlist
Wishlist

D-Lys(9)-Somatostatin

  • CAT NUMBER DCTI-D-167
  • CAS NUMBER NA
  • MOLECULAR FORMULA C76H104N18O19S2
  • MOLECULAR WEIGHT 1637.89
Wishlist
Wishlist

D-Phe(11)-Somatostatin

  • CAT NUMBER DCTI-D-165
  • CAS NUMBER NA
  • MOLECULAR FORMULA C76H104N18O19S2
  • MOLECULAR WEIGHT 1637.89 Da
Wishlist
Wishlist

D-Phe(6)-Somatostatin

  • CAT NUMBER DCTI-D-163
  • CAS NUMBER NA
  • MOLECULAR FORMULA C76H104N18O19S2
  • MOLECULAR WEIGHT 1637.89
Wishlist
Wishlist

D-Phe(7)-Somatostatin

  • CAT NUMBER DCTI-D-175
  • CAS NUMBER NA
  • MOLECULAR FORMULA C76H104N18O19S2
  • MOLECULAR WEIGHT 1637.89 Da
Wishlist
Wishlist

D-Ser(13)-Somatostatin

  • CAT NUMBER DCTI-D-179
  • CAS NUMBER NA
  • MOLECULAR FORMULA C76H104N18O19S2
  • MOLECULAR WEIGHT 1637.89
Wishlist
Wishlist

D-Trp(8)-Somatostatin

  • CAT NUMBER DCTI-D-169
  • CAS NUMBER NA
  • MOLECULAR FORMULA C76H104N18O19S2
  • MOLECULAR WEIGHT 1637.89
Wishlist
LOAD MORE
You're viewed 18 of 46 products
References
FAQ's

References

  1. Jean E. F. Rivier, “Somatostatin. Total solid phase synthesis” J. Am. Chem. Soc. 1974, 96, 9, 2986–2992
  2. McGregor, William H.; Dougherty, Joseph J., “Purification of synthetic somatostatin”, American Home Products Corp, US, US4066634A, Jan 3, 1978

Frequently Asked Questions

The common impurities found in Somatostatin include truncated Somatostatin peptides, oxidized Somatostatin, and N-terminal modified Somatostatin.

The Common impurities found during Somatostatin synthesis include incomplete coupling of amino acids, racemization of amino acids, and deletion sequences in the final peptide.

Somatostatin impurities are detected using analytical techniques such as high-performance liquid chromatography (HPLC), liquid chromatography-mass spectrometry (LC-MS), etc.

Somatostatin impurities may be removed from the drug by various purification techniques such as HPLC, size exclusion chromatography, and reverse-phase chromatography.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart